General Information of Drug (ID: DM2YGNW)

Drug Name
Dactinomycin Drug Info
Synonyms
Cosmegen; Dactinomicina; Dactinomycine; Dactinomycinum; Meractinomycin; ACT D; ACTINOMYCIN D AMP; Actactinomycin A IV; Actinomycin A IV; Actinomycin Aiv; Actinomycin I; Actinomycin IV; Actinomycin cl; Actinomycin x i; Antibiotic from Streptomyces parvullus; Chounghwamycin B; D Actinomycin; Dactinomycin D; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; Lyovac cosmegen; Oncostatin K; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin C1; Actinomycin I1; Actinomycin X 1; Actinomycin X1; HBF 386; HBF 386 meractinomycin; X 97; AD (VAN); Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin D (JP15); Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin-IV; Actinomycindioic D acid, dilactone; Acto-D; COSMEGEN (TN); Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin [USAN:BAN]; Dactinomycine [INN-French]; Dactinomycinum [INN-Latin]; NP-005932; Actinomycin D deriv. of 3H-phenoxaocardazine; GNF-PF-1977; Actinomycin-[threo-val-pro-sar-meval]; Actinomyein-theo-val-pro-sar-meval; Actinomycin-(threo-val-pro-sar-meval); O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; 1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
Indication
Disease Entry ICD 11 Status REF
Adult kidney Wilms tumor Approved [1]
Advanced cancer 2A00-2F9Z Approved [1]
Beckwith-Wiedemann syndrome Approved [1]
Childhood kidney Wilms tumor Approved [1]
Gestational trophoblastic neoplasia 2F33-2F76 Approved [1]
Hamartoma Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [2]
Wilms tumor Approved [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
457193
ChEBI ID
CHEBI:27666
CAS Number
50-76-0
TTD ID
D0P8IV
VARIDT ID
DR01203
ACDINA ID
D00983

Full List of Drug Formulations Containing This Drug

Dactinomycin 0.5mg/1ml lyophilized powder
Company Formulation ID FDA Description
Meitheal Pharmaceuticals F23701 Mannitol; Water
Mylan Institutional ; Recordati Rare Diseases F24259 Mannitol
------------------------------------------------------------------------------------

References

1 Dactinomycin FDA Label
2 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050682.